SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-20-139239
Filing Date
2020-12-23
Accepted
2020-12-23 17:22:16
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm2039003d1_f3.htm F-3 468836
2 EXHIBIT 3.1 tm2039003d1_ex3-1.htm EX-3.1 385447
3 EXHIBIT 4.7 tm2039003d1_ex4-7.htm EX-4.7 354349
4 EXHIBIT 4.8 tm2039003d1_ex4-8.htm EX-4.8 354820
5 EXHIBIT 5.1 tm2039003d1_ex5-1.htm EX-5.1 56238
6 EXHIBIT 5.2 tm2039003d1_ex5-2.htm EX-5.2 17825
7 EXHIBIT 23.1 tm2039003d1_ex23-1.htm EX-23.1 2730
8 GRAPHIC image_001.jpg GRAPHIC 3368
9 GRAPHIC image_002.jpg GRAPHIC 3128
10 GRAPHIC ex5-1_logo1.jpg GRAPHIC 3370
11 GRAPHIC ex5-1_logo2.jpg GRAPHIC 3292
12 GRAPHIC ex5-1_signature.jpg GRAPHIC 2718
  Complete submission text file 0001104659-20-139239.txt   1663999
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3 | Act: 33 | File No.: 333-251673 | Film No.: 201413587
SIC: 2834 Pharmaceutical Preparations